UIMA:F:F-UBS ETF SICAV - MSCI Europe UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 85.69

Change

-0.50 (-0.58)%

Market Cap

USD 0.32B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.30 (-1.12%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.55 (-1.07%)

USD 114.12B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.94 (+0.16%)

USD 99.24B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 94.03B
SXRZ:F iShares VII PLC - iShares Nikk..

-1.85 (-0.77%)

USD 59.61B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.16 (-1.06%)

USD 54.27B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.13 (+0.13%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.10 (+0.09%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.03 (-0.35%)

USD 40.33B
0ZC:F Zscaler Inc

+0.56 (+0.32%)

USD 37.92B

ETFs Containing UIMA:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.92% 48% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.92% 49% F 59% D-
Trailing 12 Months  
Capital Gain 19.95% 54% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.95% 55% F 61% D-
Trailing 5 Years  
Capital Gain 32.01% 55% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.01% 55% F 62% D
Average Annual (5 Year Horizon)  
Capital Gain 8.44% 68% D+ 65% D
Dividend Return 8.44% 66% D+ 58% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.86% 52% F 82% B
Risk Adjusted Return 65.64% 75% C 80% B-
Market Capitalization 0.32B 52% F 44% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike